Anne M. Kong

At St Vincent's Institute Of Medical Research
Melbourne, VIC 3065, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Biofabrication of Hierarchical Medium-Sized Branched Blood Vessel Scaffolds Utilising Negative Embodied Sacrificial Template 3D and Human-Induced Pluripotent Stem Cells.

Biofabrication of Hierarchical Medium-Sized Branched Blood Vessel Scaffolds Utilising Negative Embodied Sacrificial Template 3D and Human-Induced Pluripotent Stem Cells.

Journal: ACS biomaterials science & engineering
Published: July 09, 2026

Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy.

Cardiac SGLT2 Expression and Cell-Type-Specific Responses to Empagliflozin in iPSC-Derived Models of Diabetic Cardiomyopathy.

Journal: Journal of cardiovascular development and disease
Published: June 01, 2026

An integrated cardiac microtissue proteome map extends therapeutic remodelling by nanovesicles.

An integrated cardiac microtissue proteome map extends therapeutic remodelling by nanovesicles.

Journal: Molecular & cellular proteomics : MCP
Published: January 08, 2026

Long-read sequencing-based atlas of tissue-specific expression of DNM1L transcript variants.

Long-read sequencing-based atlas of tissue-specific expression of DNM1L transcript variants.

Journal: The FEBS journal
Published: October 21, 2025

Lyn restrains lupus via kinase-independent mechanisms that limit Toll-like receptor activation and type I interferon responsiveness.

Lyn restrains lupus via kinase-independent mechanisms that limit Toll-like receptor activation and type I interferon responsiveness.

Journal: Science advances
Published: October 17, 2025

Frataxin deficiency drives cardiac dysfunction and transcriptional dysregulation in Friedreich ataxia iPSC model.

Frataxin deficiency drives cardiac dysfunction and transcriptional dysregulation in Friedreich ataxia iPSC model.

Journal: Cell death & disease
Published: August 28, 2025

Device encapsulated MSCs for adaptive secretome therapy to effectively target ischaemic heart injury.

Device encapsulated MSCs for adaptive secretome therapy to effectively target ischaemic heart injury.

Journal: Stem cell research & therapy
Published: June 22, 2025

Methods for Assessing Scaffold Vascularization with Human Endothelial Cells.

Methods for Assessing Scaffold Vascularization with Human Endothelial Cells.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 10, 2025

Acute Inhibition of Drp1 Mitigates Adverse Cardiac Remodelling following Chronic Reperfused Myocardial Infarction.

Acute Inhibition of Drp1 Mitigates Adverse Cardiac Remodelling following Chronic Reperfused Myocardial Infarction.

Journal: Cardiovascular drugs and therapy
Published: October 13, 2024

Modelling diabetes-associated metabolic stress in human multicellular cardiac microtissues.

Modelling diabetes-associated metabolic stress in human multicellular cardiac microtissues.

Journal: Journal of molecular and cellular cardiology
Published: September 18, 2024

Cardiac-targeted delivery of a novel Drp1 inhibitor for acute cardioprotection.

Cardiac-targeted delivery of a novel Drp1 inhibitor for acute cardioprotection.

Journal: Journal of molecular and cellular cardiology plus
Published: July 01, 2024

Real-time electro-mechanical profiling of dynamically beating human cardiac organoids by coupling resistive skins with microelectrode arrays.

Real-time electro-mechanical profiling of dynamically beating human cardiac organoids by coupling resistive skins with microelectrode arrays.

Journal: Biosensors & bioelectronics
Published: June 05, 2024
Showing 1-12 of 27

Last Updated: 09/26/2026